Thermo Fisher Scientific (TMO) Net Income towards Common Stockholders (2009 - 2026)

Thermo Fisher Scientific has reported Net Income towards Common Stockholders for 18 years, with the latest figure at $1.8 billion in Q2 2026.

• Net Income towards Common Stockholders for Q2 2026 came in at $1.8 billion, up 8.66% year-over-year; the trailing twelve-month figure through Jun 2026 was $7.0 billion (up 6.93% YoY), and the FY2025 annual result was $6.8 billion, up 6.72% from the prior year.
• Net Income towards Common Stockholders climbed to $1.8 billion in Q2 2026, from $1.7 billion in the prior quarter.
• Over five years, Net Income towards Common Stockholders peaked at $2.2 billion in Q2 2022 and troughed at $1.3 billion in Q2 2023.
• A 5-year average of $1.6 billion and a median of $1.6 billion in 2023 frame the typical range for Net Income towards Common Stockholders.
• The largest YoY upside for Net Income towards Common Stockholders was 14.72% in 2023 against a maximum downside of 41.81% in 2023.
• A 5-year view of Net Income towards Common Stockholders shows it stood at $1.6 billion in 2022, then grew by 3.43% to $1.6 billion in 2023, then advanced by 12.27% to $1.8 billion in 2024, then gained by 9.29% to $2.0 billion in 2025, then declined by 12.15% to $1.8 billion in 2026.
• Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were $1.8 billion in Q2 2026, $1.7 billion in Q1 2026, and $2.0 billion in Q4 2025.